BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29880449)

  • 1. Parallel imaging compressed sensing for accelerated imaging and improved signal-to-noise ratio in MRI-based postimplant dosimetry of prostate brachytherapy.
    Sanders JW; Song H; Frank SJ; Bathala T; Venkatesan AM; Anscher M; Tang C; Bruno TL; Wei W; Ma J
    Brachytherapy; 2018; 17(5):816-824. PubMed ID: 29880449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fully Balanced SSFP Without an Endorectal Coil for Postimplant QA of MRI-Assisted Radiosurgery (MARS) of Prostate Cancer: A Prospective Study.
    Sanders JW; Venkatesan AM; Levitt CA; Bathala T; Kudchadker RJ; Tang C; Bruno TL; Starks C; Santiago E; Wells M; Weaver CP; Ma J; Frank SJ
    Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):614-625. PubMed ID: 32980498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of MRI-based postimplant dosimetric assessment in prostate brachytherapy using contrast-enhanced T1-weighted images.
    Ohashi T; Momma T; Yamashita S; Nagatsuma K; Kanai K; Kitagawa K; Takahashi S; Hanada T; Yorozu A; Shigematsu N
    Brachytherapy; 2012; 11(6):468-75. PubMed ID: 22330102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pulse sequence parameter selection on signal strength in positive-contrast MRI markers for MRI-based prostate postimplant assessment.
    Lim TY; Kudchadker RJ; Wang J; Stafford RJ; MacLellan C; Rao A; Ibbott GS; Frank SJ
    Med Phys; 2016 Jul; 43(7):4312. PubMed ID: 27370146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT- and MRI-based seed localization in postimplant evaluation after prostate brachytherapy.
    De Brabandere M; Al-Qaisieh B; De Wever L; Haustermans K; Kirisits C; Moerland MA; Oyen R; Rijnders A; Van den Heuvel F; Siebert FA
    Brachytherapy; 2013; 12(6):580-8. PubMed ID: 23876358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of an MRI-only workflow for postimplant dosimetry of low-dose-rate prostate brachytherapy: Transition from phantoms to patients.
    Nosrati R; Song WY; Wronski M; Pejović-Milić A; Morton G; Stanisz GJ
    Brachytherapy; 2019; 18(6):863-874. PubMed ID: 31337542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate brachytherapy postimplant dosimetry: seed orientation and the impact of dosimetric anisotropy in stranded implants.
    Chng N; Spadinger I; Rasoda R; Morris WJ; Salcudean S
    Med Phys; 2012 Feb; 39(2):721-31. PubMed ID: 22320782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and clinical implementation of SeedNet: A sliding-window convolutional neural network for radioactive seed identification in MRI-assisted radiosurgery (MARS).
    Sanders JW; Frank SJ; Kudchadker RJ; Bruno TL; Ma J
    Magn Reson Med; 2019 Jun; 81(6):3888-3900. PubMed ID: 30737827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deformable registration of x ray and MRI for postimplant dosimetry in low dose rate prostate brachytherapy.
    Hrinivich WT; Park S; Le Y; Song DY; Lee J
    Med Phys; 2019 Sep; 46(9):3961-3973. PubMed ID: 31215042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sliding window prior data assisted compressed sensing for MRI tracking of lung tumors.
    Yip E; Yun J; Wachowicz K; Gabos Z; Rathee S; Fallone BG
    Med Phys; 2017 Jan; 44(1):84-98. PubMed ID: 28102958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postimplant Dosimetry of Permanent Prostate Brachytherapy: Comparison of MRI-Only and CT-MRI Fusion-Based Workflows.
    Nosrati R; Wronski M; Tseng CL; Chung H; Pejović-Milić A; Morton G; Stanisz GJ
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):206-215. PubMed ID: 31627178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of interobserver differences in postimplant dosimetry following prostate brachytherapy and the efficacy of CT/MRI fusion imaging.
    Aoki M; Yorozu A; Dokiya T
    Jpn J Radiol; 2009 Nov; 27(9):342-7. PubMed ID: 19943144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.
    Mashouf S; Safigholi H; Merino T; Soliman A; Ravi A; Morton G; Song WY
    Brachytherapy; 2016; 15(6):774-779. PubMed ID: 27720310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sector analysis of dosimetry of prostate cancer patients treated with low-dose-rate brachytherapy.
    Nasser NJ; Wang Y; Borg J; Saibishkumar EP
    Brachytherapy; 2014; 13(4):369-74. PubMed ID: 24559795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulse sequence considerations for simulation and postimplant dosimetry of prostate brachytherapy.
    Ma J; Moerland MA; Venkatesan AM; Bathala TK; Kudchadker RJ; Brock KK; Frank SJ
    Brachytherapy; 2017; 16(4):743-753. PubMed ID: 28063817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncertainty in magnetic resonance imaging-based prostate postimplant dosimetry: Results of a 10-person human observer study, and comparisons with automatic postimplant dosimetry.
    Sanders JW; Tang C; Kudchadker RJ; Venkatesan AM; Mok H; Hanania AN; Thames HD; Bruno TL; Starks C; Santiago E; Cunningham M; Frank SJ
    Brachytherapy; 2023; 22(6):822-832. PubMed ID: 37716820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in MR-only seed localization for postimplant dosimetry in permanent prostate brachytherapy.
    Zijlstra F; Moerland MA; van der Voort van Zyp JRN; Noteboom JL; Viergever MA; Seevinck PR
    Med Phys; 2017 Oct; 44(10):5051-5060. PubMed ID: 28777451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of MRI-based and CT/MRI fusion-based postimplant dosimetric analysis of prostate brachytherapy.
    Tanaka O; Hayashi S; Matsuo M; Sakurai K; Nakano M; Maeda S; Kajita K; Deguchi T; Hoshi H
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):597-602. PubMed ID: 16966002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward a deep learning-based magnetic resonance imaging only workflow for postimplant dosimetry in I-125 seed brachytherapy for prostate cancer.
    Grigo J; Karius A; Hanspach J; Mücke L; Laun FB; Huang Y; Strnad V; Fietkau R; Bert C; Putz F
    Brachytherapy; 2024; 23(1):96-105. PubMed ID: 38008648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved performance of prostate DCE-MRI using a 32-coil vs. 12-coil receiver array.
    Riederer SJ; Borisch EA; Froemming AT; Grimm RC; Kawashima A; Mynderse LA; Trzasko JD
    Magn Reson Imaging; 2017 Jun; 39():15-23. PubMed ID: 28132859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.